185 related articles for article (PubMed ID: 3513813)
1. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Br J Cancer; 1986 Feb; 53(2):189-95. PubMed ID: 3513813
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
3. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
4. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
5. Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Int J Pancreatol; 1989 Jul; 5(1):85-98. PubMed ID: 2746048
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions.
Hammel P; Voitot H; Vilgrain V; Lévy P; Ruszniewski P; Bernades P
Eur J Gastroenterol Hepatol; 1998 Apr; 10(4):345-8. PubMed ID: 9855052
[TBL] [Abstract][Full Text] [Related]
7. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
[TBL] [Abstract][Full Text] [Related]
8. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.
Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S
Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227
[TBL] [Abstract][Full Text] [Related]
11. Isolation and immunohistochemical characterization of a pancreatic carcinoma-associated monoclonal antibody.
Halwani F; Cheung M; Jothy S
Exp Mol Pathol; 1990 Oct; 53(2):99-111. PubMed ID: 1702063
[TBL] [Abstract][Full Text] [Related]
12. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
[TBL] [Abstract][Full Text] [Related]
13. Expression of laminin in pancreatic neoplasms and in chronic pancreatitis.
Haglund C; Roberts PJ; Nordling S; Ekblom P
Am J Surg Pathol; 1984 Sep; 8(9):669-76. PubMed ID: 6089598
[TBL] [Abstract][Full Text] [Related]
14. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
Lyubsky S; Madariaga J; Lozowski M; Mishriki Y; Schuss A; Chao S; Lundy J
Am J Clin Pathol; 1988 Feb; 89(2):160-7. PubMed ID: 3277379
[TBL] [Abstract][Full Text] [Related]
15. Cystic neoplasms of the pancreas.
Yamaguchi K; Enjoji M
Gastroenterology; 1987 Jun; 92(6):1934-43. PubMed ID: 3471621
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
Bätge B; Bosslet K; Sedlacek HH; Kern HF; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1986; 408(4):361-74. PubMed ID: 3004013
[TBL] [Abstract][Full Text] [Related]
17. Expression of Tn, sialosyl Tn, and T antigens in human pancreas.
Itzkowitz S; Kjeldsen T; Friera A; Hakomori S; Yang US; Kim YS
Gastroenterology; 1991 Jun; 100(6):1691-700. PubMed ID: 1850375
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on the expression of the blood group antigens Le a, Le b, Le x, Le y and the carbohydrate antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Schwenk J; Makovitzky J
Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):465-76. PubMed ID: 2499104
[TBL] [Abstract][Full Text] [Related]
19. [The contribution of CA 19-9 in the differential diagnosis between chronic pancreatitis and cancer of the pancreas].
Van Gossum M; Delanghe A; Gerard M; Delcourt A; Deltenre M
Acta Gastroenterol Belg; 1987; 50(1):91-4. PubMed ID: 3480672
[No Abstract] [Full Text] [Related]
20. Expression of C-242 antigen in pancreatic ductal adenocarcinoma.
Mäkinen K; Eskelinen M; Lipponen P; Alhava E
Anticancer Res; 1995; 15(4):1605-8. PubMed ID: 7654056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]